Ascribe Bioscience

Harnessing Small Molecules for Natural Crop Protection

Ascribe Bioscience was founded in 2017, is headquartered in ITHACA, United States, lists 1–10 employees, and has $13.0M in recorded funding across 6 rounds.

Headquarters
ITHACA, New York
Employees
1–10
Founded
2017
Business Model
B2B
Total Funding
$13.0M
Last Round
$12.0M Series AOct 2025
Rounds
6

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 6 funding rounds and 10 investors for this company. The full record is or through the API.

About

Ascribe Bioscience is an Ithaca, NY-based agricultural biotechnology company developing natural crop protection solutions derived from small molecules discovered in the soil microbiome. Founded in 2017 from research at the Boyce Thompson Institute and Cornell University, Ascribe's platform applies metabolomics to identify bioactive compounds that prime plant immune systems against crop pathogens. Its flagship product, Phytalix, is a biofungicide that delivers the sustainability benefits of biologicals with the efficacy and ease of use of conventional chemical crop protection, targeting diseases including Bacterial Leaf Blight in rice. The company raised a $12 million Series A in October 2025 to advance its next-generation product pipeline.

Summary

Ascribe Bioscience is an Agtech company based in ITHACA, United States, founded in 2017. It lists 1–10 employees. It has raised $13.0M in total across 6 rounds, most recently a $12.0M Series A round in Oct 2025. Investors include Acre Venture Partners, The Yield Lab and National Science Foundation.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AOct 2025
$12.0M

Sign up to see all 6 events

Funding: Grant through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Impossible Foods

Food technology company creating plant-based meat and dairy products that replicate the taste and...

Redwood City, United States501–1000Agtech, Biotech
Series G+Total funding$1.9BNov 2021
Apeel Sciences

Apeel Sciences develops plant-based edible coatings that extend the shelf life of fresh produce, ...

GOLETA, United States201–500Agtech, Biotech
Series FTotal funding$912.9MJul 2025
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ascribe Bioscience on Indexed.vc
<a href="https://indexed.vc/companies/ascribe-bioscience"><img src="https://indexed.vc/api/badge/company/ascribe-bioscience" alt="Ascribe Bioscience on Indexed.vc" width="260" height="76" /></a>